Suntory to Buy Daiichi Sankyo’s Health Unit for $1.6 Billion

Suntory Holdings Ltd. will buy Daiichi Sankyo Healthcare, the over-the-counter pharmaceuticals subsidiary of Daiichi Sankyo Co., as it ramps up a push into the health and wellness sector.

The deal’s total consideration is expected to be about ¥246.5 billion ($1.6 billion) and will take place in phases, the companies announced Wednesday after the close of trading. The Nikkei reported the deal earlier.